Liam Kempthorne,Deniz Vaizoglu,Alexander J. Cammack,Mireia Carcolé,Pacharaporn Suklai,Bhavana Muralidharan,François Kroll,Thomas G. Moens,Lidia Yshii,Stijn Verschoren,Benedikt V. Hölbling,Eszter Katona,Alla Mikheenko,Rachel Coneys,Paula de Oliveira,Yong-Jie Zhang,Karen Jansen,Lillian M Daughrity,Alexander McGown,Tennore M. Ramesh,Ludo Van Den Bosch,Ahad A. Rahim,Leonard Petrucelli,Jason Rihel,Adrian M. Isaacs

Abstract:The most common genetic cause of both frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) is a G C repeat expansion in intron 1 of the gene. This repeat expansion undergoes bidirectional transcription to produce sense and antisense repeat RNA species. Both sense and antisense-derived repeat RNAs undergo repeat-associated non-AUG translation in all reading frames to generate five distinct dipeptide repeat proteins (DPRs). Importantly, toxicity has been associated with both sense and antisense repeat-derived RNA and DPRs. This suggests targeting both sense and antisense repeat RNA may provide the most effective therapeutic strategy. The RNA-targeting CRISPR-Cas13 systems offer a promising avenue for simultaneous targeting of multiple RNA transcripts, as they mature their own guide arrays, thus allowing targeting of more than one RNA species from a single construct. We show that CRISPR-Cas13d originating from (CasRx) can successfully reduce sense and antisense repeat transcripts and DPRs to background levels in HEK cells overexpressing repeats. CRISPR-CasRx also markedly reduced the endogenous sense and antisense repeat RNAs and DPRs in three independent patient-derived iPSC-neuron lines, without detectable off-target effects. To determine whether CRISPR-CasRx is effective , we treated two distinct repeat mouse models using AAV delivery and observed a significant reduction in both sense and antisense repeat-containing transcripts. Taken together this work highlights the potential for RNA-targeting CRISPR systems as therapeutics for ALS/FTD.

Dual-targeting CRISPR-CasRx reduces ALS/FTD sense and antisense repeat RNAs in vitro and in vivo